Vaccine for intramuscular injection

BIOLOGICAL2 trials

Sponsors

Chumakov Federal Scientific Center for Research and Development of Immune-and-Biological Products

Conditions

Coronavirus InfectionsVaccine

Phase 1

This is a Double-blind, Placebo-controlled, Randomized Study of the Tolerability, Safety and Immunogenicity of an Inactivated Whole Virion Concentrated Purified Vaccine (CoviVac) Against Covid-19

CompletedNCT05046548

Chumakov Federal Scientific Center for Research and Development of Immune-and-Biological ProductsCoronavirus Infections, Vaccine

Start: 2020-10-03End: 2021-10-01Updated: 2021-11-12

Phase 3

Double-blind, Placebo-controlled, Randomized Study of the Tolerability, Safety and Immunogenicity of an Inactivated Whole Virion Concentrated Purified Vaccine (CoviVac) Against Covid-19 of Children at the Age of 12-17 Years Inclusive

Chumakov Federal Scientific Center for Research and Development of Immune-and-Biological ProductsVaccine

Start: 2022-04-01End: 2024-02-01Target: 300Updated: 2023-03-07